Puma Biotechnology Inc (PBYI) net margin is 16.4%
Puma Biotechnology Inc (PBYI) net margin is 16.4% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full PBYI research page for quote, filings, and the rest of the model. This satellite exists so “Puma Biotechnology Inc net margin” can rank with the actual number, then send you to /stock/pbyi.